APA (7th ed.) Citation

Vaz, S. C., Groheux, D., van Nijnatten, T., Antunovic, L., Cardoso, F., Mottaghy, F., . . . Ulaner, G. A. (2025). Editorial Commentary: Should "heterogeneous response" be considered as new category for assessing treatment response in patients with breast cancer? European Journal of Nuclear Medicine & Molecular Imaging, 52(3), 801. https://doi.org/10.1007/s00259-024-07042-9

Chicago Style (17th ed.) Citation

Vaz, Sofia C., et al. "Editorial Commentary: Should "Heterogeneous Response" Be Considered as New Category for Assessing Treatment Response in Patients with Breast Cancer?" European Journal of Nuclear Medicine & Molecular Imaging 52, no. 3 (2025): 801. https://doi.org/10.1007/s00259-024-07042-9.

MLA (9th ed.) Citation

Vaz, Sofia C., et al. "Editorial Commentary: Should "Heterogeneous Response" Be Considered as New Category for Assessing Treatment Response in Patients with Breast Cancer?" European Journal of Nuclear Medicine & Molecular Imaging, vol. 52, no. 3, 2025, p. 801, https://doi.org/10.1007/s00259-024-07042-9.